REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS

被引：0
|
作者：
Schreiber, Stefan
Dignass, Axel
Peyrin-Biroulet, Laurent
Mosli, Mahmoud
Hather, Greg
Demuth, Dirk
Blake, Aimee
Curtis, Rebecca
Khalid, Javaria Mona
Loftus, Edward V., Jr.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.205
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
p155
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 : S57 - S58
  • [2] REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, L.
    Mosli, M.
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, R.
    Khalid, Mona
    Loftus, Edward V.
    [J]. INTERNIST, 2018, 59 : S55 - S56
  • [3] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    [J]. Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [4] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    [J]. JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [5] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
  • [6] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [7] REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB OVER ONE YEAR IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria M.
    Loftus, Edward V.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S338 - S338
  • [8] Real World Treatment Persistence With Vedolizumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Demuth, Dirk
    Patel, Haridarshan
    Adsul, Shashi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S370
  • [9] Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis
    Schreiber, S.
    Dignass, A.
    Peyrin-Biroulet, L.
    Hather, G.
    Demuth, D.
    Khalid, J. M.
    Loftus, E. V.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S315
  • [10] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
12345